Nephrology and Urology Devices Market Size, Share, Growth, and Industry Analysis, Types (Dialysis, Urinary Stone, Ureteral Stents, Lithotripters, Urinary Incontinence & Pelvic Organ Prolapse, Sacral Neuromodulation, Vaginal Meshes & Slings, Urethral Inserts & Pessaries, Benign Prostatic Hyperplasia, Others), Applications (Hospitals & Clinics, Ambulatory Surgical Centers), and Regional Insights and Forecast to 2035

Nephrology and Urology Devices Market Size

Global Nephrology and Urology Devices Market size was USD 6.53 Billion in 2025 and is projected to touch USD 7.03 Billion in 2026, reach USD 7.57 Billion in 2027, and grow to USD 13.67 Billion by 2035, exhibiting a CAGR of 7.67% during the forecast period from 2026 to 2035. Nearly 41% of healthcare providers are increasing investments in advanced nephrology technologies and minimally invasive urology procedures to improve patient outcomes and treatment efficiency worldwide.

The US Nephrology and Urology Devices Market continues to expand because of rising chronic kidney disease prevalence, increasing elderly population, and strong healthcare technology adoption. Nearly 46% of hospitals in the United States are expanding dialysis treatment infrastructure and advanced urinary care departments. Around 38% of healthcare providers are integrating digital patient monitoring systems into nephrology treatment programs to improve operational efficiency and long-term patient care management.

Key Findings

• Market Size: Valued at $6.53Bn in 2025, projected to touch $7.03Bn in 2026, reach $7.57Bn in 2027, and grow to $13.67Bn by 2035 at a CAGR of 7.67%.
• Growth Drivers: Nearly 41% increase in dialysis demand and 34% rise in minimally invasive urology procedures supporting healthcare device adoption globally.
• Trends: Around 38% adoption growth in digital nephrology monitoring systems and 29% increase in portable dialysis technology utilization worldwide.
• Key Players: Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc, Boston Scientific Corporation, Medtronic, Olympus Medical Systems & more.
• Regional Insights: North America 37%, Europe 27%, Asia-Pacific 26%, and Middle East & Africa 10% driven by healthcare modernization and kidney disease treatment demand.
• Challenges: Nearly 31% of healthcare facilities face device maintenance pressure while 29% report shortages of trained nephrology specialists.
• Industry Impact: Around 44% of hospitals improved patient management efficiency through advanced dialysis systems and minimally invasive urinary treatment technologies.
• Recent Developments: Nearly 23% improvement in imaging technologies and 21% reduction in treatment setup time through advanced device innovations.

The Nephrology and Urology Devices Market continues to evolve because healthcare systems are focusing more on long-term kidney disease management and minimally invasive urinary care procedures. Demand for portable dialysis systems, advanced lithotripsy equipment, robotic-assisted surgeries, and digital patient monitoring technologies is increasing steadily as healthcare providers improve patient-focused treatment strategies globally.

Unique Information about the Nephrology and Urology Devices Market: Nearly 32% of healthcare providers now prioritize home-based kidney care technologies and portable dialysis systems because patients increasingly prefer flexible treatment solutions that reduce hospital dependency and improve daily lifestyle management while maintaining long-term nephrology treatment support.

Nephrology and Urology Devices Market Trends

The Nephrology and Urology Devices Market is growing steadily because of the increasing number of kidney disorders, urinary tract diseases, and aging populations worldwide. Nearly 41% of patients with chronic kidney conditions now require long-term monitoring and supportive medical devices. Around 36% of hospitals are increasing investments in advanced dialysis systems and minimally invasive urology equipment to improve treatment efficiency and patient comfort. Demand for urinary stone management devices and ureteral stents is also rising because kidney stone cases are becoming more common due to unhealthy diets and dehydration-related conditions.

Technological improvements are changing the Nephrology and Urology Devices Market rapidly. Nearly 44% of healthcare facilities now prefer minimally invasive urology procedures because they reduce hospital stays and improve patient recovery rates. Around 38% of healthcare providers are adopting digital monitoring systems and automated dialysis technologies to improve patient management. Ambulatory surgical centers are also expanding use of lithotripters and urinary incontinence treatment devices because outpatient procedures continue to increase globally.

The aging population continues to create strong demand for nephrology and urology devices. Nearly 33% of elderly patients experience urinary incontinence or kidney-related disorders requiring regular treatment support. Demand for sacral neuromodulation devices and pelvic organ prolapse treatment products is also increasing because of rising awareness regarding women’s urological health. Around 29% of healthcare providers are focusing on advanced treatment technologies that improve patient comfort and reduce complications during procedures.

Healthcare infrastructure improvements and growing awareness regarding kidney health are supporting market expansion across developing regions. Nearly 47% of hospitals in urban healthcare systems are improving nephrology treatment facilities and urology care departments. Medical device manufacturers are also increasing investment in compact dialysis machines, advanced lithotripsy devices, and minimally invasive surgical systems to meet rising healthcare demand worldwide.

Nephrology and Urology Devices Market Dynamics

OPPORTUNITY

"Growth in minimally invasive urology procedures"

The increasing preference for minimally invasive procedures is creating major opportunities in the Nephrology and Urology Devices Market. Nearly 43% of healthcare providers now prefer minimally invasive urology treatments because they reduce patient recovery time and hospital stays. Around 37% of patients choose outpatient procedures involving lithotripters, ureteral stents, and urinary stone management devices because of improved comfort and lower surgical complications.

DRIVERS

"Rising prevalence of kidney and urinary disorders"

The increasing number of kidney diseases and urinary tract disorders continues to drive the Nephrology and Urology Devices Market globally. Nearly 39% of kidney patients require regular dialysis or nephrology treatment support. Around 34% of healthcare institutions are increasing procurement of dialysis equipment, ureteral stents, and urinary incontinence devices because patient admissions related to kidney and urological conditions are steadily rising.

RESTRAINTS

"High device and treatment maintenance costs"

One of the major restraints in the Nephrology and Urology Devices Market is the high maintenance and operational cost associated with advanced medical devices. Nearly 31% of healthcare providers report financial pressure related to dialysis equipment servicing and replacement costs. Around 27% of smaller clinics face difficulties adopting advanced nephrology systems because of limited healthcare budgets and infrastructure limitations.

CHALLENGE

"Limited specialist availability in developing regions"

A major challenge in the Nephrology and Urology Devices Market is the shortage of trained nephrologists and urology specialists in developing healthcare systems. Nearly 35% of rural healthcare facilities report delays in advanced kidney and urinary treatments because of limited specialist access. Around 29% of hospitals also face operational difficulties in managing advanced urology devices due to insufficient technical training.

Segmentation Analysis

The Nephrology and Urology Devices Market is segmented by type and application based on healthcare infrastructure and treatment requirements. The Global Nephrology and Urology Devices Market size was USD 6.53 Billion in 2025 and is projected to touch USD 7.03 Billion in 2026, reach USD 7.57 Billion in 2027, and grow to USD 13.67 Billion by 2035, exhibiting a CAGR of 7.67% during the forecast period from 2026 to 2035. Growing kidney disease prevalence, increasing urological disorders, and expanding healthcare investments continue to support market growth globally. Hospitals and clinics remain the leading segment because of high patient treatment volumes and access to advanced nephrology equipment.

By Type

Hospitals & Clinics

Hospitals and clinics dominate the Nephrology and Urology Devices Market because most advanced kidney and urinary treatments are performed in specialized healthcare facilities. Nearly 58% of dialysis procedures and urology surgeries are conducted in hospitals because of access to advanced equipment and specialist healthcare professionals. Growing patient admissions related to kidney disorders and urinary complications continue to strengthen demand across hospital networks globally.

Hospitals & Clinics held the largest share in the Nephrology and Urology Devices Market, accounting for USD 4.98 Billion in 2026, representing nearly 71% of the total market. This segment is expected to grow at a CAGR of 7.5% from 2026 to 2035, driven by increasing patient admissions, advanced healthcare infrastructure, and rising nephrology treatment demand.

Ambulatory Surgical Centers

Ambulatory surgical centers are becoming increasingly important in the Nephrology and Urology Devices Market because minimally invasive procedures and outpatient surgeries continue to rise. Around 36% of patients now prefer outpatient urinary stone treatments and lithotripsy procedures because they reduce hospital stays and treatment costs. Healthcare providers are also expanding ambulatory centers to improve treatment accessibility and operational efficiency.

Ambulatory Surgical Centers accounted for USD 2.05 Billion in 2026, representing approximately 29% of the total Nephrology and Urology Devices Market share. This segment is projected to grow at a CAGR of 8.1% from 2026 to 2035 due to rising outpatient procedures and growing demand for minimally invasive urology treatments.

By Application

Dialysis

Dialysis remains one of the leading application segments in the Nephrology and Urology Devices Market because chronic kidney disease cases continue to increase globally. Nearly 42% of kidney patients require regular dialysis support and long-term treatment monitoring. Healthcare providers are increasingly adopting automated dialysis systems and portable dialysis technologies to improve patient convenience and treatment quality.

Dialysis accounted for USD 1.76 Billion in 2026, representing nearly 25% of the total market share. This segment is expected to grow at a CAGR of 7.9% from 2026 to 2035 due to increasing kidney disease prevalence and expanding dialysis treatment infrastructure.

Urinary Stone

Urinary stone management devices are witnessing rising demand because kidney stone cases continue to increase because of dehydration, dietary changes, and sedentary lifestyles. Around 34% of urology departments are increasing use of advanced lithotripsy and stone removal systems to improve treatment outcomes and reduce recovery periods for patients.

Urinary Stone accounted for USD 1.05 Billion in 2026, representing approximately 15% of the total Nephrology and Urology Devices Market share. This segment is projected to grow at a CAGR of 7.4% from 2026 to 2035 due to increasing urinary stone treatment demand and minimally invasive procedure adoption.

Ureteral Stents

Ureteral stents remain important devices within the Nephrology and Urology Devices Market because they support urinary drainage and kidney stone management procedures. Nearly 31% of complex urinary tract procedures involve temporary ureteral stent placement to improve patient recovery and reduce complications. Hospitals are increasingly using flexible and patient-friendly stent technologies.

Ureteral Stents accounted for USD 0.84 Billion in 2026, representing nearly 12% of the total market share. This segment is anticipated to grow at a CAGR of 7.1% from 2026 to 2035 due to increasing urinary tract procedures and advanced stent product development.

Lithotripters

Lithotripters are gaining demand because healthcare providers increasingly prefer non-invasive stone fragmentation procedures for kidney stone treatment. Around 38% of urology centers now utilize advanced lithotripsy systems because they reduce surgical intervention and shorten patient recovery periods. Technological improvements are also increasing procedure success rates and patient comfort.

Lithotripters accounted for USD 0.77 Billion in 2026, representing approximately 11% of the total market share. This segment is expected to grow at a CAGR of 7.3% from 2026 to 2035 because of growing preference for non-invasive kidney stone treatments.

Urinary Incontinence & Pelvic Organ Prolapse

Urinary incontinence and pelvic organ prolapse treatment devices continue to witness growing demand because aging populations and women’s health awareness are increasing globally. Nearly 29% of elderly patients experience urinary control disorders requiring medical intervention and supportive treatment devices.

Urinary Incontinence & Pelvic Organ Prolapse accounted for USD 0.70 Billion in 2026, representing around 10% of the total market share. This segment is projected to grow at a CAGR of 7.8% from 2026 to 2035 due to increasing awareness and growing geriatric population demand.

Sacral Neuromodulation

Sacral neuromodulation devices are increasingly used for bladder control and urinary dysfunction treatment because healthcare providers seek long-term patient management solutions. Around 24% of advanced urology centers now offer neuromodulation therapy for chronic urinary disorders and bladder dysfunction conditions.

Sacral Neuromodulation accounted for USD 0.49 Billion in 2026, representing nearly 7% of the total market share. This segment is expected to grow at a CAGR of 8.3% from 2026 to 2035 due to increasing neurological urinary disorder treatment demand.

Vaginal Meshes & Slings

Vaginal meshes and slings continue to support pelvic organ prolapse and urinary incontinence treatment procedures. Nearly 22% of women’s urology treatment programs utilize sling-based procedures because of their effectiveness in improving long-term patient support and symptom management.

Vaginal Meshes & Slings accounted for USD 0.42 Billion in 2026, representing approximately 6% of the total market share. This segment is projected to grow at a CAGR of 6.9% from 2026 to 2035 due to growing women’s healthcare awareness.

Urethral Inserts & Pessaries

Urethral inserts and pessaries remain important non-surgical treatment options for urinary leakage and pelvic support conditions. Around 18% of elderly female patients prefer non-invasive urinary support products because they improve comfort and reduce surgical dependency.

Urethral Inserts & Pessaries accounted for USD 0.35 Billion in 2026, representing nearly 5% of the total market share. This segment is anticipated to grow at a CAGR of 6.8% from 2026 to 2035 because of increasing preference for non-surgical treatment options.

Benign Prostatic Hyperplasia

Benign prostatic hyperplasia treatment devices are witnessing rising demand because prostate-related urinary disorders are becoming more common among aging male populations. Nearly 27% of elderly male patients require supportive treatment procedures for urinary flow complications and bladder dysfunction.

Benign Prostatic Hyperplasia accounted for USD 0.42 Billion in 2026, representing approximately 6% of the total market share. This segment is projected to grow at a CAGR of 7.2% from 2026 to 2035 due to rising aging population and increasing prostate disorder treatments.

Others

Other nephrology and urology devices include specialized monitoring equipment, catheter systems, and supportive urinary treatment products used across healthcare facilities. Around 19% of healthcare providers continue investing in supportive nephrology technologies and advanced patient monitoring systems to improve treatment outcomes.

Others accounted for USD 0.23 Billion in 2026, representing nearly 3% of the total market share. This segment is expected to grow at a CAGR of 6.7% from 2026 to 2035 due to continuous innovation in supportive healthcare devices and patient management technologies.

Nephrology and Urology Devices Market Regional Outlook

The Global Nephrology and Urology Devices Market size was USD 6.53 Billion in 2025 and is projected to touch USD 7.03 Billion in 2026, reach USD 7.57 Billion in 2027, and grow to USD 13.67 Billion by 2035, exhibiting a CAGR of 7.67% during the forecast period from 2026 to 2035. The market is witnessing strong expansion because of rising kidney disease prevalence, increasing urinary disorders, growing healthcare investments, and wider adoption of minimally invasive urology procedures. Hospitals, specialty clinics, and ambulatory surgical centers are increasingly investing in dialysis systems, lithotripters, ureteral stents, and urinary incontinence treatment devices to improve patient care and treatment outcomes.

North America

North America remains the leading regional market for nephrology and urology devices because of advanced healthcare systems, strong medical device adoption, and increasing chronic kidney disease cases. Nearly 46% of healthcare facilities in the region are using automated dialysis technologies and minimally invasive urology systems. Around 39% of elderly patients require long-term urinary disorder management and kidney treatment support, driving demand for advanced nephrology and urology devices across hospitals and specialty clinics.

North America held the largest share in the Nephrology and Urology Devices Market, accounting for USD 2.60 Billion in 2026, representing 37% of the total market. This regional market is expected to grow at a CAGR of 7.5% from 2026 to 2035, supported by rising kidney disease prevalence, advanced healthcare infrastructure, and increasing adoption of minimally invasive urology procedures.

Europe

Europe continues to show stable growth in the Nephrology and Urology Devices Market because of increasing healthcare awareness, aging populations, and expansion of advanced urinary care facilities. Nearly 34% of hospitals in Europe are improving dialysis treatment infrastructure and digital patient monitoring systems. Around 29% of healthcare providers are focusing on advanced urinary incontinence and kidney stone treatment technologies to improve treatment efficiency and patient comfort.

Europe accounted for USD 1.90 Billion in 2026, representing 27% of the total Nephrology and Urology Devices Market share. The regional market is projected to grow at a CAGR of 7.2% from 2026 to 2035 because of expanding nephrology treatment facilities, increasing elderly populations, and higher healthcare spending across major European countries.

Asia-Pacific

Asia-Pacific is witnessing rapid growth in the Nephrology and Urology Devices Market due to rising healthcare investments, large patient populations, and increasing kidney disease cases linked to diabetes and hypertension. Nearly 41% of urban healthcare centers are investing in modern dialysis systems and advanced lithotripsy equipment. Demand for ureteral stents, urinary stone management devices, and minimally invasive procedures is also increasing steadily across developing economies.

Asia-Pacific accounted for USD 1.83 Billion in 2026, representing 26% of the total market share. This region is expected to grow at a CAGR of 8.4% from 2026 to 2035 due to expanding healthcare infrastructure, growing awareness regarding kidney disorders, and increasing patient access to advanced urology treatment technologies.

Middle East & Africa

The Middle East & Africa region is gradually expanding in the Nephrology and Urology Devices Market because healthcare modernization projects and chronic disease management programs are improving access to treatment. Nearly 24% of hospitals are increasing procurement of dialysis systems and urinary care devices to support rising patient volumes. Healthcare providers are also focusing on expanding specialized nephrology care services across urban medical centers.

Middle East & Africa accounted for USD 0.70 Billion in 2026, representing 10% of the total Nephrology and Urology Devices Market share. The regional market is projected to grow at a CAGR of 7.0% from 2026 to 2035 because of increasing healthcare investments, rising kidney disease awareness, and expanding hospital infrastructure.

List of Key Nephrology and Urology Devices Market Companies Profiled

Investment Analysis and Opportunities in Nephrology and Urology Devices Market

The Nephrology and Urology Devices Market is attracting strong investment because healthcare providers are increasing focus on kidney disease treatment and minimally invasive urinary care procedures. Nearly 44% of private healthcare investors are prioritizing dialysis technology expansion and advanced urology treatment systems. Around 38% of hospitals are increasing spending on automated dialysis devices, portable nephrology systems, and robotic-assisted urology procedures to improve treatment quality and reduce operational pressure.

Investments in outpatient treatment centers are also rising because nearly 33% of patients now prefer minimally invasive procedures that reduce hospital stays and recovery periods. Healthcare organizations are expanding ambulatory surgical centers and nephrology specialty clinics to improve accessibility and patient convenience. Around 29% of healthcare facilities are integrating digital patient monitoring technologies into nephrology and urology treatment systems to improve long-term disease management.

Emerging economies continue to provide major growth opportunities in the Nephrology and Urology Devices Market because healthcare modernization programs and chronic disease management initiatives are expanding rapidly. Nearly 36% of healthcare infrastructure projects in developing regions include nephrology treatment facilities and advanced urology departments. Demand for urinary stone management systems, ureteral stents, and urinary incontinence devices is also increasing because of rising awareness regarding urinary health and aging population growth.

New Products Development

New product development in the Nephrology and Urology Devices Market is focused on improving patient comfort, treatment efficiency, and minimally invasive healthcare solutions. Nearly 42% of manufacturers are investing in compact dialysis systems and wearable kidney monitoring technologies to support home-based treatment models. Around 35% of product innovation projects are centered around robotic-assisted urology systems and smart urinary management devices that improve treatment precision and patient outcomes.

Healthcare companies are also developing advanced lithotripters with higher stone fragmentation efficiency and reduced recovery times. Nearly 31% of recently launched urology products focus on reducing surgical complications and improving outpatient procedure success rates. Flexible ureteral stents and antimicrobial-coated urinary devices are also becoming more common because hospitals are focusing on reducing infection risks during long-term treatment procedures.

Manufacturers are increasingly integrating digital technologies into nephrology and urology devices. Around 28% of newly developed systems now include remote monitoring features and AI-supported patient management tools that help healthcare professionals monitor treatment progress more efficiently. Smart dialysis machines and connected nephrology devices are expected to improve long-term patient care and operational performance across hospitals and specialty clinics.

Recent Developments

• Fresenius Medical Care AG & Co. KGaA: Expanded production of advanced dialysis systems with nearly 24% higher treatment monitoring efficiency and improved patient support capabilities during long-term kidney care procedures.
• Baxter International, Inc: Introduced upgraded portable dialysis technology designed to reduce treatment setup time by approximately 21% while improving patient mobility and treatment flexibility.
• Boston Scientific Corporation: Enhanced lithotripsy device portfolio with improved stone fragmentation technology that increased procedure efficiency by nearly 18% during urinary stone management treatments.
• Medtronic: Expanded minimally invasive urology device solutions with advanced navigation systems that improved procedural accuracy by around 19% in complex urinary treatment procedures.
• Olympus Medical Systems: Developed advanced imaging-supported urology equipment with nearly 23% improved visualization capabilities for minimally invasive nephrology and urinary procedures.

Report Coverage

The Nephrology and Urology Devices Market report provides detailed analysis of market trends, competitive landscape, regional outlook, investment patterns, product development strategies, and application-based demand across healthcare systems worldwide. The report evaluates key factors supporting market expansion, including increasing chronic kidney disease prevalence, growing urinary tract disorders, rising elderly population, and expanding adoption of minimally invasive treatment technologies.

The report covers major device categories including dialysis systems, urinary stone management devices, ureteral stents, lithotripters, urinary incontinence treatment products, sacral neuromodulation devices, vaginal meshes, and benign prostatic hyperplasia treatment technologies. Nearly 43% of healthcare facilities covered in the report are prioritizing minimally invasive urology procedures because they reduce patient recovery time and improve treatment efficiency.

The study also highlights healthcare infrastructure developments and regional investment trends. Around 37% of hospitals included in the analysis are investing in digital nephrology monitoring systems and automated dialysis technologies to improve long-term patient management. Emerging economies are also expanding healthcare infrastructure to support rising kidney disease cases and increasing urinary health awareness.

The report evaluates market segmentation by type and application, providing detailed insights regarding hospitals, clinics, ambulatory surgical centers, dialysis treatment, urinary stone management, urinary incontinence devices, and advanced nephrology technologies. Nearly 34% of healthcare providers are increasing adoption of advanced outpatient treatment systems to improve operational efficiency and patient accessibility.

Competitive analysis within the report focuses on major manufacturers, innovation strategies, product launches, and healthcare partnerships shaping the Nephrology and Urology Devices Market globally. The report also identifies increasing demand for portable treatment systems, robotic-assisted procedures, and AI-supported healthcare monitoring solutions as major future growth areas.

Nephrology and Urology Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 6.53 Billion in 2026
Market Size Value By	USD 13.67 Billion by 2035
Growth Rate	CAGR of 7.67% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Hospitals & Clinics Ambulatory Surgical Centers By Application : Dialysis Urinary Stone Ureteral Stents Lithotripters Urinary Incontinence & Pelvic Organ Prolapse Sacral Neuromodulation Vaginal Meshes & Slings Urethral Inserts & Pessaries Benign Prostatic Hyperplasia Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample

Download FREE Sample

Full Name*

Business Email*

Phone No.

Security Code

Submit

Frequently Asked Questions

• What value is the Nephrology and Urology Devices Market expected to touch by 2035?

  The global Nephrology and Urology Devices Market is expected to reach USD 13.67 Billion by 2035.

• What CAGR is the Nephrology and Urology Devices Market expected to exhibit by 2035?

  The Nephrology and Urology Devices Market is expected to exhibit a CAGR of 7.67% by 2035.

• Who are the top players in the Nephrology and Urology Devices Market?

  Asahi Kasei Corporation, B.Braun Group, Baxter International, Inc, Boston Scientific Corporation, C.R. Bard, Inc, Coloplast AS, Cook Medical, Dornier MedTech, Fresenius Medical Care AG & Co. KGaA, Nikkiso Co.Ltd., Nipro Corporation, NxStage Medical, Inc., Olympus Medical Systems, Rockwell Medical Technologies, Inc., Terumo Corporation, Svenska Cellulosa Aktiebolaget (SCA), ONTEX International N.V., Kimberly-Clark Corporation, First Quality Enterprises, Inc., Teleflex Incorporated, Siemens Healthineers, Medtronic, Medline Industries, Inc., STORZ Medical AG

• What was the value of the Nephrology and Urology Devices Market in 2025?

  In 2025, the Nephrology and Urology Devices Market value stood at USD 6.53 Billion.

Related Reports

Transcranial Dopplers (Tcd) Market Endometrial Suction Curettes Market AV Fistula Needles Market Compartment Syndrome Monitoring Devices Market Mucosal Atomization Devices Market Computer Assisted Surgical (Cas) Systems Market